Immunosuppression for Ipilimumab-Related Toxicity Can Causepneumocystispneumonia but Spare Antitumor Immune Control

OncoImmunology - United States
doi 10.1080/2162402x.2015.1040218
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Infliximab for IPILIMUMAB-Related Colitis--Letter

Clinical Cancer Research
Cancer ResearchOncology
2015English

Immune-Related Fulminant Myocarditis in a Patient Receiving Ipilimumab Therapy for Relapsed Chronic Myelomonocytic Leukaemia

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

SBRT for Unresectable Pancreatic Cancer Can Improve Local Control With Minimal Toxicity

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Immune Suppression by PD-L2 Against Spontaneous and Treatment-Related Antitumor Immunity

Clinical Cancer Research
Cancer ResearchOncology
2019English

P3.04-28 Can Ipilimumab Restore Immune Response in Advanced NSCLC After Progression on Anti PD1/PDL1 Agents?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Combined Forecast—inventory Control Procedure for Spare Parts

Journal of the Operational Research Society
ManagementProbabilityMarketingUncertaintySimulationManagement ScienceStatisticsManagement Information SystemsModelingStrategyOperations Research
2000English

Immunosuppression and the Immune Response to Transplantation

Canadian Journal of Infectious Diseases
1993English

Maintenance Spare Parts Planning and Control: A Framework for Control and Agenda for Future Research

Production Planning and Control
IndustrialManufacturing EngineeringStrategyManagement ScienceComputer Science ApplicationsManagementOperations Research
2014English

Case-Control Studies Can Be Useful but Have Many Limitations

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy